One study reported one rat out of 8 expressing human islet amyloid polypeptide (HIP) as a model for diabetes developed pancreatitis when treated with sitaglyptin for 12 weeks (70)
(2015) Biochemical Pharmacology
doi: 10.3892/mmr.2014.2555 78 ZhouT.ZhangM.ZhaoL.LiA.QinX
We address GLP-1 side effects the same week they come up
Mace Scott, backed by a team of physicians, nurse practitioners, and registered nurses, our comprehensive approach goes beyond quick fixes, providing tailored care and expert guidance to help you achieve sustainable, long-term results
Aging populations, sedentary lifestyles, and urbanization contribute to increasing rates of metabolic disorders, creating a larger target patient pool for GLP-1 therapies